Increased pressor response to noradrenaline in pituitary dependent Cushing's syndrome

• Published in: Clinical endocrinology (Oxford) 1999-09, Vol.51 (3), p.293-299
• Main Authors: Heaney, Anthony P., Hunter, Steven J., Sheridan, Brian, Brew Atkinson
• Format: Article
• Language: English
• Subjects: Adult; Aged; Biological and medical sciences; Case-Control Studies; Cushing Syndrome - complications; Cushing Syndrome - physiopathology; Diastole; Endocrinopathies; Female; Humans; Hypertension - etiology; Hypertension - physiopathology; Hypothalamus. Hypophysis. Epiphysis (diseases); Male; Medical sciences; Middle Aged; Non tumoral diseases. Target tissue resistance. Benign neoplasms; Norepinephrine; Pulse; Regression Analysis; Systole
• ISSN: 0300-0664; 1365-2265
• DOI: 10.1046/j.1365-2265.1999.00766.x

OBJECTIVES The mechanism of hypertension in Cushing's syndrome remains undetermined. Some studies have demonstrated an increased sensitivity to pressor agents but it is not clear if patients with Cushing's syndrome of different aetiologies demonstrate this finding. We have examined pressor sensitivity in a group of patients with Cushing's disease (pituitary dependent hypercortisolism) by measuring blood pressure during incrementally increasing infusions of noradrenaline. METHODS Eight subjects (7 female, 1 male), aged 42.2 ± 4.5 years (mean ± SEM) with Cushing's disease were studied. Eight age‐ and sex‐matched control subjects were also studied. Four of the eight controls and five patients with Cushing's disease had elevated blood pressure. All medication for this had been stopped at least seven days prior to the study. After subjects ate a light breakfast, ECG leads and a sphygmomanometer were attached, an intravenous cannula was inserted and all subjects then rested quietly for 60 minutes. Noradrenaline was then infused intravenously for 10‐minute periods at concentrations of 0.01, 0.03, 0.07, 0.11 and 0.18 μg/kg/minute. RESULTS On the day of the study the baseline blood pressures and pulse rates in the patients with Cushing's disease (blood pressure; 138/87 ± 6/3 mmHg, pulse 76.5 ± 4.8 beats/minute) and controls (blood pressure; 126/86 ± 6/6 mmHg, pulse 71.2 ± 3.7 beats/minute) were not significantly different. The mean change in diastolic blood pressure from baseline at the time of the peak increase or when the test was stopped was 21.5 ± 4.7 mmHg in Cushing's disease compared to 7.0 ± 2.5 mmHg in controls (P = 0.03). The mean change in mean arterial pressure from baseline at the time of the peak increase or when the test was stopped was 22.0 ± 4.0 mmHg in Cushing's disease compared to 13.0 ± 2.4 mmHg in controls (P = 0.03). No significant difference in mean change of systolic pressure (26.0 ± 4.6 vs. 25 ± 4.0 mmHg) or pulse rates (− 11.1 ± 1.8 vs. − 4.7 ± 2.6) was seen in the group with Cushing's disease as compared to the control group. CONCLUSIONS We conclude that patients with pituitary–dependent Cushing's syndrome have enhanced pressor diastolic and mean arterial responses to noradrenaline and this may be an important underlying mechanism for the hypertension seen in this particular group of Cushing's syndrome patients.